Clinical research organizations (CROs) like Veristat play a crucial role in the success of clinical trials. These organizations help sponsors and investigators design, conduct, and manage clinical trials in an ethical and regulated manner. Therefore, choosing the right CRO is a major decision that affects the trial’s success. In the selection process, one of the factors to consider is the size of the CRO. In this post, we will explore how size influences the selection of the CRO.
Size of CRO
The landscape of clinical trials has dramatically changed in recent years. This has led to changes such as adopting adaptive designs and approaches like at home clinical trials. These trials allow participants to participate from home, reducing the need to travel to the central location. For this reason, sponsors must select CROs that can efficiently manage at-home clinical trials. Infrastructure, resources, and experience are some things to think about when choosing a CRO based on the size of the organization. For clinical trials to be done at home, there needs to be a lot of infrastructure, such as remote monitoring devices, telemedicine, and electronic data capture (EDC). In the same way, at-home trials need technology, staff, and equipment, among other things, to make sure they go smoothly. Lastly, any clinical trial requires the research staff to have experience in the field. Even though at-home trials are new, choosing a CRO with some experience handling such trials is vital.
Small-sized CROs are a good fit for at-home clinical trials for some reasons. They are more adaptable and sensitive to the needs of the client, which makes the research more focused on the patient. This is essential for at-home trials that require rapid adaptation to changing circumstances. This patient-centeredness is possible because small CROs do not have a large client base; hence, they can channel their resources to the current client. Small CROs may also have more experience with niche areas, such as working with specific populations or rare diseases. However, they may need more resources and infrastructure to manage remote trials. As a result, sponsors may face challenges in implementing at-home clinical trials with small CROs.
Medium-sized CROs are better front than small CROs. This is because medium CROs have better resources and may be better equipped to handle remote trials. In addition, medium CROs may have experience in managing remote trials and possible access to advanced technologies that can facilitate remote monitoring and data collection. But these organizations might only be able to handle small-scale trials, which could be a problem for sponsors who want to do large-scale clinical trials at home.
Lastly, we have the large-sized CROS. As expected, these organizations have the necessary resources, expertise, and infrastructure to run remote trials. In the same way, they may have a lot of experience running large-scale trials because they have the technology to collect data and keep an eye on things from afar. Due to their handling of large-scale clinical trials, large CROs may only sometimes guarantee a patient-centered approach for your trials.
The size of the CROs influences their ability to manage at-home clinical trials effectively. In essence, the size of the CRO may only meet some of the checks, and you may have to compromise. At that point, ensure the strengths of the CRO outweigh its weaknesses.